Get our Free Drug Patent Expiration Updates

Serving hundreds of leading biopharmaceutical companies globally:

Johnson and Johnson
US Army
Citi
Cantor Fitzgerald
Fuji
US Department of Justice
McKesson
Accenture
Express Scripts

Generated: November 16, 2018

DrugPatentWatch Database Preview

Drug Master Files for: CALCIUM CHLORIDE; MAGNESIUM CHLORIDE; POTASSIUM CHLORIDE; SODIUM ACETATE; SODIUM CHLORIDE; SODIUM LACTATE

« Back to Dashboard


CALCIUM CHLORIDE; MAGNESIUM CHLORIDE; POTASSIUM CHLORIDE; SODIUM ACETATE; SODIUM CHLORIDE; SODIUM LACTATE Drug Master Files

DMF No. Status Type Submission Date Holder Subject
10232 I II 3/6/1993 LABOCHIM SPA LEUCOVORIN CALCIUM
10238 I II 4/14/1993 BK LADENBURG GMBH DENTPHOS C (CALCIUM HYDROXYLAPATITE)
10759 I II 3/3/1994 AKZO NOBEL CHEMICALS BV DISSOLVINE E-CA-10 (EDETATE CALCIUM DISODIUM USP)
11685 I II 4/20/1995 SYNTHELABO PHARMACIE UREA-CALCIUM ACETYLSALICYLATE
11995 A II 6/10/1996 MERCK SANTE SAS CALCIUM ACAMPROSATE NEW DRUG SUBSTANCE
1262 I II 12/16/1968 GENERAL ELECTRIC CO CALCIUM 45, PRODUCT SPECIFICATIONS AND PROCESS DESCRIPTIONS
DMF No. Status Type Submission Date Holder Subject

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial


Drug Master File Glossary

STATUS OF DMFS

  • A = Active. This means that the DMF was found acceptable for filing, administratively, and is up-to-date.
  • I = Inactive
  • N = Not an assigned number
  • P = DMF Pending Filing Review

TYPES OF DMFs

  • Type I Manufacturing Site, Facilities, Operating Procedures, and Personnel (no longer applicable)
  • Type II Drug Substance, Drug Substance Intermediate, and Material Used in Their Preparation, or Drug Product
  • Type III Packaging Material
  • Type IV Excipient, Colorant, Flavor, Essence, or Material Used in Their Preparation
  • Type V FDA Accepted Reference Information

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Medtronic
Julphar
QuintilesIMS
McKinsey
Baxter
Federal Trade Commission
Fish and Richardson
Harvard Business School
Cerilliant

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.